Source - LSE Regulatory
RNS Number : 8578R
ABCAM PLC
10 March 2021
 

For immediate release

10 March 2021

ABCAM PLC

("Abcam" or the "Company")

Director/PDMR Shareholding Notification

Cambridge, UK: Abcam plc (Nasdaq: ABCM; AIM: ABC), a global leader in the supply of life science research tools, has been notified of the following dealings in Abcam's shares by certain Directors of the Company as follows:

 

·      Alan Hirzel, Chief Executive Officer, purchased 2,500 Ordinary Shares at a price of £14.857 pence per share on Tuesday 9 March 2021.

·      Michael Baldock, Chief Financial Officer, purchased 5,000 American Depositary Receipts at a price of US$20.66 on Tuesday 9 March 2021.

 

The notifications for Mr Hirzel and Mr Baldock can be found below.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Alan Hirzel

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Issue of Conditional shares under the rules of the Abcam plc Long Term Incentive Plan (LTIP) and sale of sufficient shares to fund the tax, national insurance and dealing charges. Balance retained.

c)

Currency

GBP

d)

Price(s) and volume(s)

Acquisition of shares on release of award

Price(s)

Volume(s)

£14.856924 per share

2,500


Sale of shares to satisfy income tax, national insurance and dealing charges



e)

Aggregated information

Acquisition of shares on release of award

Sales of shares to satisfy income tax, national insurance and dealing charges

Price(s)

Aggregated Volume(s)

Aggregated Total

£14.856924

2,500

£37,142.31




f)

Date of the transaction

09 March 2021

g)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Michael Baldock

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

American Depositary Shares

 

 

US0003802040/ABCM

b)

Nature of the transaction

Issue of Conditional shares under the rules of the Abcam plc Long Term Incentive Plan (LTIP) and sale of sufficient shares to fund the tax, national insurance and dealing charges. Balance retained.

c)

Currency

USD

d)

Price(s) and volume(s)

Acquisition of shares on release of award

Price(s)

Volume(s)

USD$20.66

5,000


Sale of shares to satisfy income tax, national insurance and dealing charges



e)

Aggregated information

Acquisition of shares on release of award

Sales of shares to satisfy income tax, national insurance and dealing charges

Price(s)

Aggregated Volume(s)

Aggregated Total

US$20.66

5,000

$103,300




f)

Date of the transaction

09 March 2021

g)

Place of the transaction

The Nasdaq Global Select Market

 

Forward-Looking Statements

 

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this announcement that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding award eligibility and LTIP issuance and value sufficiency under the laws of the United Kingdom, as well as statements that include the words "expect," "intend," "plan," "believe," "project," "forecast," "estimate," "may," "should," "anticipate" and similar statements of a future or forward-looking nature. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation: a regional or global health pandemic, including the novel coronavirus ("COVID-19"), which has adversely affected elements of our business, could severely affect our business, including due to impacts on our operations and supply chains; challenges in implementing our strategies for revenue growth in light of competitive challenges; developing new products and enhancing existing products, adapting to significant technological change and responding to the introduction of new products by competitors to remain competitive; failing to successfully identify or integrate acquired businesses or assets into our operations or fully recognize the anticipated benefits of businesses or assets that we acquire; if our customers discontinue or spend less on research, development, production or other scientific endeavours; and the important factors discussed under the caption "Risk Factors" in Abcam's prospectus pursuant to Rule 424(b) filed with the U.S. Securities and Exchange Commission ("SEC") on 22 October 2020, which is on file with the SEC and is available on the SEC website at www.sec.gov, as such factors may be updated from time to time in Abcam's other filings with the SEC. Any forward-looking statements contained in this announcement speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. Abcam disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQBLFFFXLZBBK
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJBell logo

Related Charts